A Win For Flexion Therapeutics, Inc.
Mon, Oct 11, 2021 at 05:30 PM
Flexion Therapeutics, Inc. (FLXN:NASDAQ) soared at $9.17, representing a gain of 58.7%. On Fri, Oct 08, 2021, FLXN:NASDAQ hit a New 2-Week Intraday Low of $5.4. The stock appeared on our News Catalysts scanner on Mon, Oct 11, 2021 at 04:49 PM in the 'ACQUISITION' category. From Fri, Sep 24, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
About Flexion Therapeutics, Inc. (FLXN:NASDAQ)
Flexion Therapeutics Inc is a development stage specialty pharmaceutical company. The Company is engaged in the development and commercialization of novel, long-acting, injectable pain therapies including; anti-inflammatory and analgesic therapies.
Top 10 Gainers:
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 93.86%
- Adamas Pharmaceuticals, Inc. (ADMS:NASDAQ), 75.05%
- Flexion Therapeutics, Inc. (FLXN:NASDAQ), 58.65%
- PROG (PROG:NASDAQ), 58.52%
- U.S. Well Services, Inc. (USWS:NASDAQ), 25.83%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 23.97%
- Sphere 3D Corp. (ANY:NASDAQ), 23.77%
- GOTU (GOTU:NYSE), 19.35%
- Blue Apron Holdings, Inc. (APRN:NYSE), 17.4%
- Hexindai Inc. (HX:NASDAQ), 15.44%